Interphase cytogenetic analysis of erbB2 and topollα co‐amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ

International Journal of Cancer

Volumn 64, Issue 1, 1995, Pages 18-26

  Murphy, Dermot S ^a,b   McHardy, Peter ^a   Coutts, Jacqueline ^a   Mallon, Elizabeth A ^c   David George, W ^b   Kaye, Stanley B ^a   Brown, Robert ^a   Nicol Keith, W ^a  

^a CRC Department of Medical Oncology   (United Kingdom)

^b Department of Surgery ^*  (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; CARCINOMA IN SITU; CHROMOSOME 17; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTERPHASE; ONCOGENE; PRIORITY JOURNAL;

ANEUPLOIDY; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, INFILTRATING DUCT; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 17; DNA TOPOISOMERASES, TYPE II; GENE AMPLIFICATION; GENES, ERBB-2; HUMAN; IN SITU HYBRIDIZATION, FLUORESCENCE; RECEPTOR, ERBB-2; SUPPORT, NON-U.S. GOV'T;

EID: 0028927502     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910640106     Document Type: Article

References (47)

1. Detection of amplified sequences in human tumour cell lines by fluorescence in situ hybridisation
2. Genotypic, characterisation of prostatic carcinomas: a combined cytogenetic, flow cytometry, and in situ hybridisation study
3. Somatic mutations and human breast cancer
4. Antigen unmasking on formalin‐fixed paraffin‐embedded tissue sections
5. Expression of topoisomerase II alpha and beta in an adenocarcinoma cell line carrying amplified topoisomerase II alpha and retinoic acid receptor alpha genes
6. Maintenance of p53 alterations throughout breast cancer
7. Molecular genetic changes in human breast cancer
8. Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumours using chromosome‐specific repetitive DNA probes
9. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q
10. In situ detection of supernumerary aberrations of chromosome‐specific repetitive DNA targets in interphase nuclei in human melanoma cell lines and tissue sections
11. Rapid generation of chromosome‐specific alphoid DNA probes using the polymerase chain reaction
12. Molecular cytogenetics in human cancer diagnosis
13. Breast cancer
14. Cloning and characterisation of the 5′‐flanking region of the human topoisomerase IIα gene
15. Detection of numerical chromosome aberrations using in situ hybridisation in paraffin sections of routinely processed bladder cancers
16. Interphase cytogenetics: an approach to the detection of genetic aberrations in tumours
17. Y chromosome loss in esophageal carcinoma: an in situ hybridisation study
18. Amplification and overexpression of the erbB gene in human tumours: its involvement in tumour development, significance as a prognostic factor and potential as target for cancer therapy
19. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridisation
20. Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridisation
21. erbB2 amplification in breast cancer analysed by fluorescence in situ hybridisation
22. Comparative genomic hybridisation: a rapid new method for detecting and mapping DNA amplification in tumours
23. Co‐amplification of erbB2, topoisomerase Hα and retinoic acid receptor α genes in breast cancer and allelic loss at topoisomerase I on chromosome 20
24. Amplification of the topoisomerase Hα gene in a non‐small‐cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase Hα and β loci in normal tissue
25. Interphase cytogenetics in paraffin sections of lung tumours by non‐isotopic in situ hybridisation
26. Chromosome 11q13 abnormalities in human cancer
27. Detecting genetic changes in human tumour cells: have scientists “gone fishing”?
28. Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion
29. Detection of mycn gene amplification and deletions of chromosome 1p in neuroblastoma by in situ hybridisation using routine histologic sections
30. The HERZ (cerbB‐2) oncogene is frequently amplified in in situ carcinomas of the breast
31. Extensive genetic alterations in prostate cancer revealed by dual PCR and Fish analysis
32. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridisation
33. Defining the extent and nature of cytogenetic events in prostatic adenocarcinoams: paraffin FISH vs. metaphase analysis
34. Correlation between c‐erbB‐2 amplification and risk of recurrent disease in node‐negative breast cancer
35. Interphase cytogenetics of tumours
36. Allelic loss on chromosome 17 in ductal carcinoma in situ of the breast
37. c‐erbB‐2 amplification in node‐negative human breast cancer
38. Amplification of the 11q13 region in human carcinoma cell lines
39. Topoisomerase IIα co‐amplification with erbB2 in human primary breast cancer cell lines: relationship to m‐AMSA and mitoxantrone sensitivity
40. Regulation and mechanisms of mammalian gene amplification
41. Detection of 1p36 deletions in paraffin sections of neuroblastoma tissues
42. DNA topoisomerase‐targeting antitumour agents and drug resistance
43. Interphase cytogenetics on paraffin sections of malignant pleural mesothelioma, a comparison to conventional karyotyping and flow cytometric studies
44. p53 mutations and c‐erbB‐2 amplification in intraductal and invasive breast carcinomas of high histologic grade
45. Interphase cytogenetics in paraffin sections of routinely processed hydatidiform moles and hydropic abortions
46. The molecular pathology of human breast cancer
47. The role of DNA topoisomerases in recombination and genome stability: a double‐edged sword?